Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Myhep Dvir Tablet
Manufacturer/Marketed By : Mylan Pharmaceuticals Pvt Ltd
$197.76 $46.60
Myhep Dvir Tablet is a potent antiviral medication that combines Daclatasvir (60 mg) and Sofosbuvir (400 mg) to effectively combat chronic hepatitis C, a viral liver infection that primarily affects...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Daclatasvir 60 mg+ Sofosbuvir 400 mg
Active Pharmaceutical Ingredient
Myhep Dvir Tablet
197.76$
46.60$
Myhep Dvir Tablet is a potent antiviral medication that combines Daclatasvir (60 mg) and Sofosbuvir (400 mg) to effectively combat chronic hepatitis C, a viral liver infection that primarily affects adults. This innovative formulation works by inhibiting specific viral proteins, thereby significantly decreasing the replication of the Hepatitis C virus in the body. Patients using Myhep Dvir can expect a reduction in viral load, contributing to improved liver health and overall well-being. It’s essential to follow your healthcare provider's guidance while taking this medication, as it may not be suitable for individuals with certain pre-existing health conditions or those on specific medications. Potential side effects may include fatigue, headache, and nausea, so monitoring for any adverse reactions is crucial. Myhep Dvir is typically prescribed as part of a comprehensive treatment plan tailored to each patient's unique needs. Always consult with a healthcare professional before starting treatment to ensure it aligns with your medical history and health status. This medication represents a significant advancement in hepatitis C therapy, offering hope for many seeking a cure.
Active Pharmaceutical Ingredient
Uses
• Treatment of chronic hepatitis C virus (HCV) infection
Benefits
Daclatasvir is a direct-acting antiviral medication that works by inhibiting a protein called NS5A, which is essential for the replication of the hepatitis C virus. Sofosbuvir is another direct-acting antiviral medication that works by inhibiting a different protein called NS5B, which is also essential for the replication of the hepatitis C virus. These are used to increase its effectiveness in treating HCV.
Side Effects
Myhep Dvir Tablet cause some side effects like all medications, although not everyone will experience them.
Most Common Side Effects
• Headache
• Fatigue
• Nausea
• Diarrhea
• Difficulty sleeping
Common Side Effects
• Liver problems (such as elevated liver enzymes or liver failure)
• Allergic reactions (such as rash or difficulty breathing)
• Abnormal heart rhythms
How To Use
Take Myhep Dvir Tablet exactly as prescribed by your doctor. The recommended dose and dosing schedule may vary depending on your medical condition, age, weight, and other factors. It should be taken with food. Swallow the tablet as a whole with a glass of water. Patients should not chew, crush, or break the tablet, as this may affect the effectiveness of the medication. Avoid doubling the dose to compensate for the missed dose.
Safety Advice
• Breast Feeding: It is unknown if Myhep Dvir Tablet is excreted in human breast milk, so breastfeeding women should consult a healthcare provider before taking this medication.
• Alcohol: Drinking alcohol while taking Myhep Dvir Tablet is generally not recommended. Alcohol can have negative effects on the liver, which can exacerbate the effects of hepatitis C.
• Liver: Myhep Dvir tablets are primarily used to treat hepatitis C. Patients having other liver ideas should consult a doctor before taking them.
• Lungs: Patients should consult a healthcare provider with any pre-existing lung conditions with their healthcare provider before starting treatment with Myhep Dvir Tablet.
• Driving: Patients should always monitor their response to the Myhep Dvir Tablet medication and be cautious when driving or operating machinery if they experience any side effects that may impair their ability to do so safely.
• Pregnancy: The safety of Myhep Dvir Tablet during pregnancy is not well-established. Pregnant women should consult their healthcare provider about their pregnancy status before receiving this medication.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.